Johnson & Johnson (JNJ) Barclays 28th Annual Global Healthcare Conference summary

Strategic vision and innovation

• Emphasis on a long legacy of surgical innovation, now focused on advancing robotic surgery with a unique, integrated table-based robotic platform.

• OTTAVA platform designed to address unmet needs in workflow, flexibility, and efficiency for surgical teams and hospitals.

• Integration of trusted instruments and digital ecosystem (Polyphonic) to unify open, laparoscopic, and robotic procedures.

• Focus on reducing surgical complications and improving economic outcomes through secure staple technology.

• Commitment to global leadership and broad accessibility across diverse healthcare settings.

Product design and operational benefits

• OTTAVA’s integrated arms stow invisibly, allowing ORs to serve all types of surgery and maximize space.

• Surgeons can deploy one or multiple arms as needed, enhancing procedural flexibility.

• Consistent experience across modalities improves workflow and procurement for hospitals.

• Flexible design supports efficient use of ORs, reducing idle time and increasing utilization.

• Platform is adaptable to various global OR designs and care sites, including ASCs.

Commercial and procedural strategy

• Initial market entry in the U.S., followed by expansion to Japan, Europe, Middle East, and Africa.

• First regulatory submission targets upper GI procedures, with rapid expansion planned for other indications like inguinal hernia.

• MONARCH platform expands into endoluminal and percutaneous robotics, including urology for kidney stones.

• Intention to serve all surgical specialties and become a leader in soft tissue robotics.

• Commercial approach aims for broad presence and accessibility, leveraging existing global infrastructure.